FDA Inspection 677065 — Ratiopharm GmbH
The FDA completed an inspection of Ratiopharm GmbH on Aug 6, 2010 in Ulm. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 6, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ulm (Germany)
Additional details
Sponsor, Contract Research Organization